Active LitigationMDL 3181
Spinal Cord Stimulator Lawsuit Facts
TorHoerman Law is actively accepting claims for the Spinal Cord Stimulator Lawsuit.
Active Litigation·MDL 3181
TorHoerman Law is actively accepting claims for the Spinal Cord Stimulator Lawsuit.
Boston Scientific spinal cord stimulator lawsuit claims center on allegations that certain spinal cord stimulation devices may have malfunctioned, failed, or caused patients to experience serious complications after implantation.
Patients who suffered complications from a defective spinal cord stimulator may pursue a spinal cord stimulator lawsuit against medical device manufacturers to seek compensation for injuries and related medical costs.
TorHoerman Law is reviewing claims involving injuries linked to spinal stimulator devices.

Boston Scientific manufactures spinal cord stimulation systems intended to manage chronic pain when other treatments have not provided adequate relief.
Some patients have reported device malfunction, lead migration, loss of stimulation, and painful electric shocks after implantation.
These reported complications have raised concerns about spinal cord stimulator risks and whether patients and physicians received adequate safety warnings.
Lawsuits allege that design problems, manufacturing defects, or insufficient testing caused abnormal device behavior and severe injuries.
In some cases, patients required revision surgery, replacement of device components, or complete device removal.
Claims against medical device companies like Boston Scientific may involve failure to warn, negligence, breach of warranty, or alleged violations of federal medical device requirements.
If you or a loved one suffered complications or injuries related to a Boston Scientific spinal cord stimulator device, you may be eligible to file a defective medical device lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chat feature on this page to find out if you qualify for a spinal cord stimulator lawsuit.
The Boston Scientific spinal cord stimulator lawsuit concerns allegations that the company introduced and marketed implanted pain devices without sufficiently evaluating later modifications or providing complete information about their risks.
Plaintiffs allege that Boston Scientific obtained the original premarket approval for its spinal cord stimulation system partly through published research involving similar devices made by other companies rather than independent clinical studies demonstrating the safety and effectiveness of its own system.
They further claim that Boston Scientific later introduced substantially modified devices through successive PMA supplements without adequate new clinical evaluation.
The lawsuits allege that certain devices failed mechanically or therapeutically after patients received a permanent spinal cord stimulator.
Reported problems include loss of pain relief, lead migration, burning sensations, painful electrical shocks, autonomic dysfunction, and neurological injury.
Certain plaintiffs also allege that Boston Scientific representatives routinely entered operating rooms, advised medical personnel about lead positioning and stimulation testing, participated in device programming, recommended settings, and adjusted or directed adjustments to stimulation parameters.
Plaintiffs contend that some representatives crossed from technical support into medical decision-making without a license.

Patients may require repeated reprogramming, revision procedures, complete device removal, or multiple surgeries when the system cannot provide stable therapy. The most serious claims may involve lasting nerve damage, mobility limitations, autonomic symptoms, or permanent disability.
Symptoms such as neck pain or chest pain may also be relevant when they begin after abnormal stimulation or device malfunction, but medical records must distinguish those symptoms from the patient’s original pain condition or another medical cause.
The JPML created Boston Scientific MDL 3181 because the federal lawsuits share factual questions involving regulatory compliance, device performance, risk disclosures, and representative involvement.
Boston Scientific disputes the allegations and has argued that plaintiffs’ claims may be limited or barred by federal preemption.
The strength of an individual claim depends on the exact Boston Scientific device implanted, the alleged malfunction, programming and device records, the treatment required afterward, and medical evidence connecting the device to the patient’s serious injuries.
On June 5, 2026, the U.S. Judicial Panel on Multidistrict Litigation created MDL 3181 and transferred federal Boston Scientific spinal cord stimulator cases to the Central District of California before Judge Josephine L. Staton.
The JPML limited the proceeding to Boston Scientific rather than combining competing manufacturers whose devices, regulatory histories, internal records, and alleged defects involve different factual questions.
Plaintiffs in the MDL raise shared allegations involving device performance, post-approval modifications, regulatory compliance, safety warnings, and the conduct of Boston Scientific representatives.

Common allegations in Boston Scientific MDL 3181 include:
An MDL (multidistrict litigation) coordinates similar federal lawsuits before one judge for shared discovery, expert issues, motions, and other pretrial proceedings.
Unlike a class action, each plaintiff keeps an individual lawsuit and must prove the specific device, injuries, treatment, and damages involved in the claim.
MDLs are commonly used for medical device lawsuits because plaintiffs may raise similar defect and warning allegations while experiencing substantially different complications and financial losses.
Cases that do not settle or otherwise resolve during the MDL may later return to their original courts for individual trials.
Boston Scientific manufactures spinal cord stimulation systems used to treat chronic nerve pain when other therapies have not provided adequate relief.
These implantable neuromodulation devices deliver electrical impulses near the spinal cord to modify pain signals before they reach the brain.
Patients typically undergo a temporary stimulation trial before permanent implantation.
Physicians evaluate whether stimulation produces measurable pain relief before proceeding with spinal cord stimulator surgery.

Boston Scientific spinal cord stimulation systems commonly referenced in medical records include include traditional and burst stimulation devices such as:
Some of these systems are marketed with MRI-conditional labeling depending on the pulse generator model and lead configuration used during implantation.
Yes, Boston Scientific spinal cord stimulator systems and components have been included in several FDA-classified recalls.
In 2024, the FDA classified a Class II recall involving WaveWriter Alpha 16 and WaveWriter Alpha 32 implantable pulse-generator kits, covering 77,674 devices distributed worldwide.
The devices could reset during charging, temporarily stop stimulation for approximately 10 to 15 seconds, and cause undesired sensations when therapy turned off and restarted, potentially leading some patients to request revision or replacement surgery.
In June 2026, the FDA also posted a Class II recall involving 43 Boston Scientific Clik X Anchors because the sterile components may not have had adequate sterility assurance.
FDA records also identify older recalls involving Precision system connectors, leads, extensions, programmers, and other spinal cord stimulator components.
A recall does not automatically establish a lawsuit, and a potential claim depends on whether the patient received an affected model or component and experienced an injury connected to the recalled issue.
Spinal cord stimulators are implanted systems used to manage chronic pain when medication, physical therapy, and other treatments have not provided sufficient relief.
Boston Scientific systems are designed to deliver consistent electrical impulses through leads positioned in the epidural space near the spinal cord.
These mild electrical pulses are intended to interrupt pain signals before they are fully processed by the brain.
Patients may receive spinal cord stimulation for conditions such as failed back surgery syndrome, complex regional pain syndrome, or chronic pain associated with degenerative disc disease.
When leads migrate, components fail, or stimulation changes unexpectedly, patients may experience new symptoms, loss of pain relief, or complications requiring additional treatment.
Lawsuits against medical device companies, including Boston Scientific, allege that certain systems caused serious injuries or were marketed without adequate warnings about device failure and revision surgery.

Reported spinal cord stimulator risks and complications include:
Patients who received a Boston Scientific spinal cord stimulator implanted and later developed serious complications may be able to pursue a claim.
Many spinal cord stimulator lawsuits involve situations where a device used to treat chronic pain later caused device malfunction, worsening symptoms, or injuries that required additional medical care.
Reported circumstances in spinal cord stimulator cases often include device failure, electrical shocks, lead migration, infection, or revision procedures after spinal cord stimulator implantation.

If a Boston Scientific spinal cord stimulator caused serious complications, the process of determining whether a claim may proceed generally involves several steps:
After these initial steps, the claim may proceed through the process of a product liability claim, beginning with the filing of a complaint setting out the alleged defect and resulting harm.
The case then moves through pleadings and pre-trial proceedings, where the parties address legal issues and may engage in settlement discussions.
If the matter is not resolved, it may proceed to trial, where the court evaluates liability and any damages based on the record.
A Boston Scientific spinal cord stimulator claim begins with collecting records that identify the implanted device and document what changed after spinal cord stimulator implantation.
Device identification plays a key role in evaluating a Boston Scientific spinal cord stimulator lawsuit. Surgical records and implant cards usually list the exact spinal cord stimulator device, including the model name, serial number, and the implantable pulse generator used during spinal cord stimulator implantation.
Those details help determine whether the implanted system was a Boston Scientific spinal cord stimulation device, such as WaveWriter Alpha, Spectra WaveWriter, WaveWriter, or WaveWriter Alpha Prime, and which leads or components were placed near the spinal cord during the procedure.

Types of personal injury evidence commonly collected in spinal cord stimulator cases include:
These records help identify the specific Boston Scientific spinal cord stimulation device and document whether device malfunction or spinal cord stimulator complications developed after implantation.
A Boston Scientific spinal cord stimulator lawsuit may address the medical and financial consequences that follow spinal cord stimulator complications.
Some patients undergo additional procedures after spinal cord stimulator implantation, while others continue treatment for symptoms such as worsening pain, electrical shocks, or loss of stimulation.
Medical records in spinal cord stimulator lawsuits may show repeat treatment after the device was implanted to treat chronic pain.
In some situations, the spinal cord stimulator implanted during the original procedure must be revised or removed through additional spinal cord stimulator surgery.

Damages in spinal cord stimulator cases often involve:
Recent lawsuits and court filings describe allegations that some Boston Scientific spinal cord stimulators malfunctioned after implantation, leading to complications such as lead migration, painful stimulation changes, and additional surgery to revise or remove the device.
Plaintiffs in these cases claim the devices failed to perform as intended or caused injuries after implantation.
TorHoerman Law is actively reviewing claims from individuals who received Boston Scientific spinal cord stimulators and later experienced serious complications, device failure, or revision or explant surgery.
Our legal team examines medical records, device information, and treatment history to determine whether a spinal cord stimulator lawsuit may be appropriate.

If you received a Boston Scientific spinal cord stimulator and later experienced severe complications or corrective surgery, contact TorHoerman Law for a free case review.
Our law firm can evaluate your records and discuss whether legal options may be available based on the circumstances of your case.
Patients are filing these cases because some people allege that they suffered a spinal cord stimulator injury after implantation and later experienced serious complications such as electric shocks, nerve damage, device migration, burns, lead fracture or displacement, battery malfunction, infection, and other neurological problems, including allegations involving spinal cord injuries.
Lawsuits in this area of medical device litigation usually seek compensation for medical costs, emotional distress, and other damages, while also attempting to hold spinal cord stimulator manufacturers accountable for how these products were designed, tested, marketed, and monitored within the broader medical device industry.
Many of these claims also focus on whether manufacturers complied not just with the technical requirements of the regulatory system, but with its underlying safety purpose, especially given the volume of reported problems.
Public reporting based on FDA data describing well over 80,000 adverse event reports tied to spinal cord stimulators.
Several Boston Scientific spinal cord stimulation systems have been referenced in spinal cord stimulator lawsuits involving reported device malfunction, lead migration, or other spinal cord stimulator complications.
Models that may be identified in these spinal cord stimulator cases include:
The specific spinal cord stimulator implanted during the implantation procedure is important.
Surgical records and medical records usually identify the model and components used, which helps determine whether one of these Boston Scientific spinal cord stimulation devices is involved.
Yes.
In 2024 the FDA posted a Class II recall involving certain Boston Scientific WaveWriter Alpha implantable pulse generator kits, which are part of spinal cord stimulation systems used to treat chronic pain.
Reported effects associated with the issue included temporary loss of stimulation or inadequate pain relief, unexpected stimulation changes, and electrical shocks or uncomfortable sensations.
The recall applied to specific components used during spinal cord stimulator implantation, and patients were advised to consult their physician if symptoms occurred.
Reports in spinal cord stimulator lawsuits and safety databases describe several problems involving certain spinal cord stimulation devices.
Some patients state that the spinal cord stimulator implanted to help manage chronic pain later stopped providing effective pain relief or caused new symptoms.
Complaints described in spinal cord stimulator cases often involve changes in stimulation affecting the spinal cord or problems with device components.
Reported issues include:
Some patients also report nerve damage, continued chronic nerve pain, or other serious complications after spinal cord stimulator surgery.
Revision or removal of a spinal cord stimulator implanted during spinal cord stimulator surgery can be an important fact in spinal cord stimulator lawsuits.
Some spinal cord stimulator cases involve patients who needed another procedure after the original spinal cord stimulator implantation.
Situations that may appear in a cord stimulator lawsuit include:
When medical records show these events, the claim may be evaluated as a defective medical device case within broader spinal cord stimulator litigation.
In addition to Boston Scientific, spinal cord stimulator lawsuits have named Abbott, Medtronic, and Nevro as defendants.
The JPML was notified of cases involving all four manufacturers while considering federal centralization, and plaintiffs have since filed separate MDL motions for Abbott and Nevro claims.
The JPML declined to create one industrywide MDL because each manufacturer’s devices, regulatory history, evidence, and alleged defects involve different factual questions.
Other manufacturers named in spinal stimulator lawsuits include:
Spinal cord stimulators are used to help alleviate chronic pain when more conservative treatment has not provided enough relief.
Boston Scientific’s approved SCS systems are indicated as an aid in managing chronic, intractable pain of the trunk or limbs, including pain associated with complex regional pain syndrome, failed back or surgery syndrome, and chronic low back and leg pain.
SCS devices may be used for:
A spinal cord stimulator uses thin electrical leads placed in the epidural space and connected to a pulse generator implanted beneath the skin.
The generator sends mild electrical pulses through the leads to modify or interrupt pain signals before the brain fully processes them.
Patients can usually control the stimulation within programmed limits using a handheld remote or other external controller.
The device does not cure the underlying condition, and complications may occur if the leads migrate, the system malfunctions, or the stimulation changes unexpectedly.
The manufacturer and model may appear on the patient implant card, operative report, programming records, or device interrogation reports generated during follow-up visits.
Boston Scientific systems may be identified by names such as WaveWriter Alpha, Spectra WaveWriter, Precision Montage, or Precision Spectra.
Records listing St. Jude Medical generally refer to devices now associated with Abbott rather than Boston Scientific.
Correctly identifying the manufacturer, pulse generator, leads, and serial numbers is important because each company’s devices, recalls, and lawsuit allegations are different.
Patients who no longer have their implant card can request records from the implanting physician, hospital, pain-management clinic, or device representative.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Spinal Cord Stimulator Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.